Navigation Links
OPKO Management and Israel's Minister of Science Open TASE Trading in Honor of OPKO'S Dual-Listing on TASE
Date:8/21/2013

TEL-AVIV, Israel, August 21, 2013 /PRNewswire/ --

This morning the Tel Aviv Stock Exchange (TASE) held an opening bell ceremony honoring the dual listing of the OPKO Health, Inc., which was attended by  Israel's Minister of Science, Technology and Space and senior management from OPKO, PROLOR Biotech and TASE.

     (Logo: http://photos.prnewswire.com/prnh/20130117/588933)

     (Photo: http://photos.prnewswire.com/prnh/20130821/635903 )

The Minister of Science, Technology and Space, Yaacov Peri, stated the OPKO's dual listing on TASE constitutes another stage in the process of establishing Israel as an international leader in the bio-pharma industries. The listing of multinational concern on the Tel Aviv Stock Exchange should not be taken for granted, particularly during these times of regional and economic turmoil. The dual listing underscores Israel's strength. "I hope that OPKO's listing is a harbinger for other international multinational companies."

Dr. Phillip Frost, OPKO's Chairman and CEO stated the "We at OPKO believe that we will profit from PROLOR's talent and experience. The merger between OPKO and PROLOR is a prime example of what cooperation between Israel and the U.S. and other countries can yield. PROLOR contains talented professionals, which to my mind constitute the heart and soul of Israel and the Israeli mind. What Israel needs today is 10 companies like Teva; one is not enough. I am certain that PROLOR, together with OPKO, will become a success story like Teva in the near future, and it is interesting to see that there are other companies here harboring the same potential. The Israeli mind does not cease to amaze and is definitely worth study and investment."

Ester Levanon, TASE CEO, said that "This is a special day for TASE. OPKO's dual listing is recognition of the special position the biomed sector holds at the Tel Aviv Stock Exchange, and it constitutes a vote of confidence in Israel's capital market. In the past years TASE has managed to turn into a hub for biomed companies. At the end of 2005 only 12 biomed firms were listed on TASE. Today 59 companies are listed, 7 of which are dual listed. This sector is larger than what is currently found on European exchanges."

In the picture (right to left): Shai Novik, CEO PROLOR; Dr. Phillip Frost, Chairman and CEO, OPKO; Ester Levanon, CEO, TASE; Yaacov Peri, Minister of Science, Technology and Space; Dr. Ron Malka, Interim Chairman of the Board, TASE.

Credit for photograph: Moshe Shay with compliments


    
    Orna Goren
    Deputy Manager
 
    Marketing & Communications Unit
    The Tel-Aviv Stock Exchange
    
    T: +972(3)5677405
    F: +972(3)5105376
    M: +972(52)3400843
    E: ornag@tase.co.il
    W: http://www.tase.co.il
    A: 54 Ahad Ha'am St., Tel-Aviv 65202, Israel



'/>"/>
SOURCE Tel Aviv Stock Exchange Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
2. Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference
3. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
4. Pain Management Therapeutics Market is Expected to Decline to USD 29.47 Billion Globally by 2018: Transparency Market Research
5. LIMS 24/7 and Ayrris: Big-Data Lab Management for Production-Scale NGS
6. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
7. Molecular Biomarkers for Cancer Detection and Management
8. Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
9. VG Life Sciences, Inc. Announces Management Changes
10. Elsevier Supports Russias ROSATOM Knowledge Management Program
11. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):